In a revealing experiment, and using an AD transgenic mouse model with TTR genetic reduction (AD/TTR+/-), it was reported that IDIF administration resulted in decreased amyloid burden and total Aβ brain levels, and in the improved cognitive function of the animals [102]. Here, TTR is linked to Alzheimer disease.